MEDNAX Announces Acquisition of Multi-Specialty Practice in Texas
Established in 2000, NICS is a private practice that employs 27 full
time clinicians (14 physicians, 12 advanced practitioners and 1
audiologist). The practice provides neonatology (Level II and Level
III), maternal-fetal medicine, newborn hearing screen and pediatric
services to seven hospitals and one office-based practice across the
The practice has more than 40,000 annual patient days across its hospitals and provider specialties.
“The practice is excited to be joining MEDNAX’s national network and look forward to the value and quality this will bring from a continuum of care perspective to the many communities we serve across multiple specialties,” said Tung Giep, M.D., NICS President and CEO. “In addition, as health care consolidation becomes the norm, we know that MEDNAX’s leadership and infrastructure as well as its national research, education and clinical quality initiatives will enhance our strategic market growth throughout the state of Texas.”
This acquisition adds to the services
This was a cash transaction and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.
ABOUT
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,”
“will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
View source version on businesswire.com: http://www.businesswire.com/news/home/20170206005341/en/
Source:
MEDNAX, Inc.
Charles Lynch, 954-384-0175, x 5692
Vice
President, Strategy and Investor Relations
charles_lynch@mednax.com